Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery

Sergey E. Borisov, Lia D'Ambrosio, Rosella Centis, Simon Tiberi, Keertan Dheda, Jan Willem Alffenaar, Rohit Amale, Evgeny Belilowski, Judith Bruchfeld, Barbara Canneto, Justin Denholm, Raquel Duarte, Aliasgar Esmail, Alex Filippov, Lina Davies Forsman, Mina Gaga, Shashank Ganatra, Gaida Anastasia Igorevna, Barbara Lazaro Mastrapa, Vinicio ManfrinSelene Manga, Andrey Maryandyshev, Gilbert Massard, Pablo González Montaner, Jai Mullerpattan, Domingo Juan Palmero, Agostina Pontarelli, Apostolos Papavasileiou, Emanuele Pontali, Rodolfo Romero Leyet, Antonio Spanevello, Zarir Farokh Udwadia, Pietro Viggiani, Dina Visca, Giovanni Sotgiu, Giovanni Battista Migliori

Research output: Contribution to journalArticlepeer-review


Objectives: No study evaluated the contribution of adjunctive surgery in bedaquiline-treated patients. This study describes treatment outcomes and complications in a cohort of drug-resistant pulmonary tuberculosis (TB) cases treated with bedaquiline-containing regimens undergoing surgery. Methods: This retrospective observational study recruited patients treated for TB in 12 centres in 9 countries between January 2007 and March 2015. Patients who had surgical indications in a bedaquiline-treated programme-based cohort were selected and surgery-related information was collected. Patient characteristics and surgical indications were described together with type of operation, surgical complications, bacteriological conversion rates, and treatment outcomes. Treatment outcomes were evaluated according to the time of surgery. Results: 57 bedaquiline-exposed cases resistant to a median of 7 drugs had indication for surgery (52 retreatments; 50 extensively drug-resistant (XDR) or pre XDR-TB). Sixty percent of cases initiated bedaquiline treatment following surgery, while 36.4% underwent the bedaquiline regimen before surgery and completed it after the operation. At treatment completion 90% culture-converted with 69.1% achieving treatment success; 21.8% had unfavourable outcomes (20.0% treatment failure, 1.8% lost to follow-up), and 9.1% were still undergoing treatment. Conclusions: The study results suggest that bedaquiline and surgery can be safely and effectively combined in selected cases with a specific indication.

Original languageEnglish
Pages (from-to)35-39
Number of pages5
JournalJournal of Infection
Issue number1
Publication statusPublished - Jan 1 2019


  • pulmonary rehabilitation
  • TB, MDR-TB
  • XDR-TB, surgery

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery'. Together they form a unique fingerprint.

Cite this